GENE ONLINE|News &
Opinion
Blog

2025-11-29|

Study Explores Scottish Dementia Care Professionals’ Perspectives on AI-Based Pain Assessment Tool PainChek

by GOAI
Share To

A recent study conducted by researchers Nyangu, Dunham, and Samuriwo examines the perspectives of dementia care professionals in Scotland regarding the use of PainChek®, a digital tool designed to assess pain in individuals living with dementia. The research, soon to be published in *BMC Geriatrics*, highlights the challenges faced by caregivers in accurately identifying and managing pain among dementia patients, a critical issue within geriatric care.

The study explores how PainChek®—a technology that uses artificial intelligence to analyze facial expressions and other indicators of discomfort—could assist professionals in addressing this need. Researchers gathered insights from care providers to understand their experiences and opinions on the tool’s effectiveness, usability, and potential impact on patient outcomes. The findings aim to shed light on whether such innovations could improve pain management practices for individuals who may struggle to communicate their discomfort due to cognitive impairments associated with dementia.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: November 29, 2025

©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Author
Related Post
AI-Driven Healthcare Transformation at Healthcare Expo Taiwan 2025
2025-12-05
LATEST
AI-Driven Healthcare Transformation at Healthcare Expo Taiwan 2025
2025-12-05
How AWS Cloud Is Transforming Global Smart Healthcare and Trusted Research Environments
2025-12-03
MedTex 2025: Taiwan as Gateway for AI-Driven Medical Innovation and Global Capital
2025-12-03
FDA CBER Director Vinay Prasad Issues November 2025 Memo Addressing Vaccine Development and Regulatory Challenges
2025-12-03
FDA to Review 16 Drug Applications Including 8 New Molecular Entities by Year-End
2025-12-03
Stephen Durso Named CEO of Altimmune Inc. as Vipin Garg Steps Down
2025-12-03
Janux Therapeutics Shares Halve Despite Positive Phase I Trial Results for Solid Tumor Therapy
2025-12-03
EVENT
2025-12-06
The 67th ASH Annual Meeting and Exposition
Orlando, Florida, USA
2025-12-04
2025 Healthcare+ Expo Taiwan
Taipei, Taiwan
Scroll to Top